2.4. Outcomes
TG, diarrhea, nausea,
ADVERSE EVENTS
The primary outcomes were the change in blood lipids (TC, TG, HDL-C, LDL-C, non-HDL-C, and LDL-C to HDL-C ratio) from baseline to 120 days. Secondary outcomes included the changes in CIMT from baseline to 120 days. The safety outcomes included biochemical indicators (e.g., coagulation, liver function, renal function, blood glucose, and blood routine), physical examination parameters (e.g., systolic blood pressure and diastolic blood pressure), and adverse events (e.g., nausea, vomiting, and diarrhea). 